Audentes Therapeutics - Gene Therapy Manufacturing Facility
Courtesy of Audentes Therapeutics.
Sanford, N.C.
Audentes Therapeutics is planning to construct a $109 million gene therapy manufacturing facility in Sanford, N.C. The 135,000-sf project will support the production of genetic medicines based on adeno-associated virus vectors for the treatment of rare neuromuscular diseases. The center is expected to be operational by 2021. Audentes Therapeutics is a subsidiary of Astellas Pharma.
